Antithrombin III Prevents Blood Pressure Elevation and Proteinuria Induced by High Salt Intake in Pregnant Stroke-Prone Spontaneously Hypertensive Rats
スポンサーリンク
概要
- 論文の詳細を見る
In pregnant stroke-prone spontaneously hypertensive rats, salt-loading causes symptoms similar to those of human preeclampsia, such as hypertension and proteinuria. To seek evidence of the therapeutic potential in preeclampsia of antithrombin III (AT III), which is a serine protease inhibitor active on various enzymes of the coagulation cascade, we examined the effect of consecutive treatment with AT III on hypertension and proteinuria in this animal model. Salt-loading (2% NaCl diet) caused a significant elevation of systolic blood pressure on day 15-17 and of urinary protein excretion on day 17-19 of gestation, as compared with animals fed a normal diet. AT III, administered i.v. at a dose of 60 or 300 U/kg/d for 10 d from day 9-11 to 18-20,attenuated these pathological changes in a dose-dependent manner. Histological examination of the kidney revealed that AT III prevented the occurrence of arteriosclerosis and thickening of the capillary basement membrane. However, the pathological changes induced by salt-loading were not attributable to activation of the blood coagulation system. These results demonstrate that AT III has preventive action against salt-induced hypertension and proteinuria in pregnancy through a mechanism largely independent of its anticoagulant action. AT III may thus be beneficial for the treatment of clinical symptoms of preeclampsia.
- 公益社団法人日本薬学会の論文
- 1996-06-15
著者
-
Akira Toshiaki
ミドリ十字
-
Akira Toshiaki
Pharmacology Laboratories Research Division The Green Cross Corporation
-
UCHIDA Takeshi
Pharmaceutical Research Laboratory, Kirin Brewery Co., Ltd.
-
Uchida Takeshi
Pharmaceutical Research Laboratory Kirin Brewery Co. Ltd.
-
Uchida Takeshi
Pharmacology Laboratories Research Division The Green Cross Corporation
-
SHINYAMA Hiroshi
Pharmacology Laboratories, Research Division, The Green Cross Corporation
-
YAMANAGA Katsumi
Pharmacology Laboratories, Research Division, The Green Cross Corporation
-
YAGUCHI Masafumi
Pharma Research and Development Division, Drug Development Research Laboratories, Hoechst Japan Ltd.
-
WATANABE Masahiro
Pharmacology Laboratories, Research Division, The Green Cross Corporation
-
KAGITANI Yoshio
Pharmacology Laboratories, Research Division, The Green Cross Corporation
-
Kagitani Yoshio
Pharmacology Laboratories Research Division The Green Cross Corporation
-
Yamanaga Katsumi
Pharmacology Laboratories Research Division The Green Cross Corporation
-
Shinyama Hiroshi
Pharmacology Laboratories Research Division The Green Cross Corporation
-
Yaguchi Masafumi
Pharma Research And Development Division Drug Development Research Laboratories Hoechst Japan Ltd.
-
Watanabe Masahiro
Pharmacology Laboratories Research Division The Green Cross Corporation
関連論文
- Structure-antitumor Activity Relationship of Semi-synthetic Spicamycin Derivatives
- Synthesis and Antitumor Activities of Glycine-exchanged Analogs of Spicamycin
- Effect of α-Galactosylceramides on Bone Marrow Cells in Vitro and Hematopoiesis in Vivo
- Enhancing Effects of Agelasphin-11 on Natural Killer Cell Activities of Normal and Tumor-Bearing Mice
- Immunostimulatory and Antitumor Activities of Monoglycosylceramides Having Various Sugar Moieties
- Antithrombin III Prevents Blood Pressure Elevation and Proteinuria Induced by High Salt Intake in Pregnant Stroke-Prone Spontaneously Hypertensive Rats